LU87935A1 - Methode de preparation de derives de furo(3,4-c)pyridine sous forme non-racemique - Google Patents

Methode de preparation de derives de furo(3,4-c)pyridine sous forme non-racemique Download PDF

Info

Publication number
LU87935A1
LU87935A1 LU87935A LU87935A LU87935A1 LU 87935 A1 LU87935 A1 LU 87935A1 LU 87935 A LU87935 A LU 87935A LU 87935 A LU87935 A LU 87935A LU 87935 A1 LU87935 A1 LU 87935A1
Authority
LU
Luxembourg
Prior art keywords
group
compound
radical
hydrogen atom
formula
Prior art date
Application number
LU87935A
Other languages
English (en)
French (fr)
Inventor
Charles R Eck
Paul Ahrens
Rae Marie Saltzstein
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of LU87935A1 publication Critical patent/LU87935A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/182—Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU87935A 1990-05-14 1991-05-14 Methode de preparation de derives de furo(3,4-c)pyridine sous forme non-racemique LU87935A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/523,238 US5130252A (en) 1990-05-14 1990-05-14 Resolution of furopyridine enantiomers and synthetic precursors thereof

Publications (1)

Publication Number Publication Date
LU87935A1 true LU87935A1 (fr) 1992-03-03

Family

ID=24084213

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87935A LU87935A1 (fr) 1990-05-14 1991-05-14 Methode de preparation de derives de furo(3,4-c)pyridine sous forme non-racemique

Country Status (32)

Country Link
US (1) US5130252A (sv)
JP (1) JPH05117277A (sv)
KR (1) KR910020015A (sv)
AR (1) AR247762A1 (sv)
AT (1) AT400445B (sv)
AU (1) AU642368B2 (sv)
BE (1) BE1007016A3 (sv)
CA (1) CA2042421C (sv)
CH (1) CH682488A5 (sv)
DE (1) DE4115681C2 (sv)
DK (1) DK88991A (sv)
DZ (1) DZ1499A1 (sv)
ES (1) ES2033574B1 (sv)
FI (1) FI97807C (sv)
FR (1) FR2661919B1 (sv)
GB (1) GB2244056B (sv)
GR (1) GR1001593B (sv)
HK (1) HK131993A (sv)
IE (1) IE65891B1 (sv)
IT (1) IT1248743B (sv)
LU (1) LU87935A1 (sv)
MA (1) MA22154A1 (sv)
MY (1) MY107567A (sv)
NL (1) NL194615C (sv)
NO (1) NO180308C (sv)
NZ (1) NZ238009A (sv)
OA (1) OA09352A (sv)
PT (1) PT97657B (sv)
SE (1) SE510808C2 (sv)
TN (1) TNSN91035A1 (sv)
TW (1) TW226998B (sv)
ZA (1) ZA913461B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0221494D0 (en) * 2002-09-16 2002-10-23 Generics Uk Ltd Novel processes for the preparation of 1.3-dihydro-6-methylfuro (3,4-c) pyndin derivatives
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
US20110251396A1 (en) * 2003-07-17 2011-10-13 Gilead Sciences, Inc. Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
WO2005009446A1 (en) * 2003-07-17 2005-02-03 Cotherix, Inc. Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
US20050113314A1 (en) * 2003-08-29 2005-05-26 Fong Benson M. Cicletanine in combination with oral antidiabetic and/or blood lipid-lowering agents as a combination therapy for diabetes and metabolic syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
US7375112B2 (en) * 2005-01-05 2008-05-20 Medicure International Inc. Compounds and methods for regulating triglyceride levels
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
JP2010514841A (ja) * 2007-01-03 2010-05-06 グレン ブイ． コルネット， 肺疾患および心疾患の処置におけるシクレタニンおよびｐｋｃ阻害剤
WO2011053519A1 (en) * 2009-10-29 2011-05-05 Merck Sharp & Dohme Corp. Diuretics

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN156817B (sv) * 1981-02-10 1985-11-09 Scras
US4985365A (en) * 1981-11-28 1991-01-15 Sumitomo Chemical Company, Ltd. Process for producing optically active benzyl alcohol compound
EP0101076B1 (en) * 1982-08-13 1989-01-04 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Process for production of optically active oxazolidinone derivative
IN160104B (sv) * 1983-04-05 1987-06-27 Scras
JPS59216590A (ja) * 1983-05-24 1984-12-06 Ube Ind Ltd 光学活性フエニルプロパルギルアルコ−ル誘導体の製法
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
JPS60224494A (ja) * 1984-04-24 1985-11-08 Nissan Chem Ind Ltd α−メチルベンジルアルコ−ル類の光学分割法
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
JPS61289899A (ja) * 1985-06-18 1986-12-19 Kanegafuchi Chem Ind Co Ltd 光学活性２−ハロ−１−フエニルエタノ−ルおよびそのエステルの製造法
US4916074A (en) * 1986-10-30 1990-04-10 Chisso Corporation Process for producing optically active compounds
JP2691986B2 (ja) * 1987-08-28 1997-12-17 チッソ株式会社 ピリジン骨格を有する光学活性化合物の製造法
DE3737335A1 (de) * 1987-11-04 1989-05-18 Basf Ag Verfahren zur herstellung eines biokatalysators und dessen verwendung zur razematspaltung
DE3990349T1 (de) * 1988-04-06 1990-04-26 Scras Stereospezifisches verfahren zur herstellung von enantiomeren von furo(3,4-c)pyridin, so erhaltene verbindungen und therapeutische zusammensetzungen auf basis dieser verbindungen
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
NL8801311A (nl) * 1988-05-20 1989-12-18 Stamicarbon Fenylglycidaatstereoisomeren, omzettingsprodukten daarvan met 2-nitrothiofenol en de bereiding van diltiazem.
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
SE510808C2 (sv) 1999-06-28
GB2244056A (en) 1991-11-20
AU642368B2 (en) 1993-10-14
DK88991A (da) 1991-11-15
IE911628A1 (en) 1991-11-20
HK131993A (en) 1993-12-10
KR910020015A (ko) 1991-12-19
DZ1499A1 (fr) 2004-09-13
BE1007016A3 (fr) 1995-02-21
NO911852D0 (no) 1991-05-13
PT97657A (pt) 1992-02-28
CH682488A5 (fr) 1993-09-30
OA09352A (fr) 1992-09-15
GR1001593B (el) 1993-03-31
DK88991D0 (da) 1991-05-13
ITMI911255A0 (it) 1991-05-08
GB2244056B (en) 1993-08-11
NO180308B (no) 1996-12-16
SE9101431L (sv) 1991-11-15
MA22154A1 (fr) 1991-12-31
FI97807B (sv) 1996-11-15
NO911852L (no) 1991-11-15
SE9101431D0 (sv) 1991-05-13
GB9109810D0 (en) 1991-06-26
CA2042421A1 (en) 1991-11-15
AU7620091A (en) 1991-11-14
IT1248743B (it) 1995-01-26
JPH05117277A (ja) 1993-05-14
ITMI911255A1 (it) 1992-11-08
MY107567A (en) 1996-04-30
GR910100180A (en) 1992-07-30
PT97657B (pt) 1998-09-30
DE4115681A1 (de) 1991-11-21
FI912315A (sv) 1991-11-15
IE65891B1 (en) 1995-11-29
ES2033574B1 (es) 1994-02-01
NL9100749A (nl) 1991-12-02
ZA913461B (en) 1992-02-26
AR247762A1 (es) 1995-03-31
AT400445B (de) 1995-12-27
NZ238009A (en) 1992-11-25
FR2661919A1 (fr) 1991-11-15
FI97807C (sv) 1997-02-25
ES2033574A1 (es) 1993-03-16
ATA98291A (de) 1995-05-15
FR2661919B1 (fr) 1994-12-30
NL194615C (nl) 2002-09-03
CA2042421C (en) 2000-08-22
NO180308C (no) 1997-03-26
FI912315A0 (sv) 1991-05-13
NL194615B (nl) 2002-05-01
TW226998B (sv) 1994-07-21
TNSN91035A1 (fr) 1992-10-25
DE4115681C2 (de) 2003-10-30
US5130252A (en) 1992-07-14

Similar Documents

Publication Publication Date Title
BE1007016A3 (fr) METHODE DE PREPARATION DE DERIVES DE FURO (3,4-c) PYRIDINE SOUS FORME NON-RACEMIQUE.
BE851310A (fr) Nouveaux derives de la tetrahydro-equinocandine b
EP0382634B1 (fr) Nouveaux dérivés de la pyridazine, procédé de préparation et compositions pharmaceutiques en contenant
FR2511679A1 (fr) Nouvelles imidazotetrazinones, leur preparation et les medicaments qui les contiennent
CA2539849A1 (fr) Derives d'arylalkylcarbamates, leur preparation et leur application en therapeutique
FR2647676A1 (fr) Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase
FR2478096A1 (fr) Lactones physiologiquement actives presentant des proprietes immunopotentialisatrices et anti-inflammatoires, leur procede de production et les compositions pharmaceutiques les renfermant
FR2623808A1 (fr) Nouveaux derives flavonoides (benzyl-4 piperazinyl-1)-2 oxo-2 ethylene substitues, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
EP0418933A1 (fr) Dérivés d'alcadiènes, leurs préparations, les médicaments les contenant et produits intermédiaires
BE1004995A3 (fr) Nouveau derive de 5h-benzodiazepine, compositions pharmaceutiques le contenant et procede pour les preparer.
CH615441A5 (sv)
EP0034529B1 (fr) Nouveaux dérivés de la triazoloquinazolinone et leurs sels avec les acides, leur préparation, leur application comme médicaments, et les compositions les renfermant
EP0370902B1 (fr) Utilisation de dérivés du chromanne pour preparer un medicament utile pour le traitement des états dépressifs
EP0536035A1 (fr) Dérivés de benzonaphtyridine-1,8 et compositions anti-microbiennes
BE1004489A3 (fr) Derives de dihydropyrimidothiazine, leur procede de preparation et compositions pharmaceutiques les contenant.
EP0119896B1 (fr) Nouveaux dérivés de l'amino-5 dithiole-1,2 one-3, leur préparation et les compositions médicinales qui les contiennent
BE1004520A3 (fr) Synthese asymetrique des derives de la furo [3,4-c] pyridine.
EP0772630A1 (fr) Derives de streptogramine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2584072A1 (fr) Nouveaux derives d'isoquinoleine, leur procede de preparation, leur application en therapeutique et produits intermediaires
BE832435R (fr) Perfectionnements relatifs aux antibiotiques
EP0188150A1 (fr) Procédé de préparation d'isomères optiques de thiazolo [3,2-a] pyrimidines, les nouveaux isomères ainsi obtenus, les compositions pharmaceutiques qui les contiennent et les intermédiaires pour mettre en oeuvre ce procédé
JPH05284986A (ja) 光学活性１，４−ジヒドロピリジン化合物の製造方法
BE896797A (fr) Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments.
JPS61260059A (ja) プロピオン酸誘導体のｄ体の製造方法
FR2723748A1 (fr) Substances physiologiquement actives de type caledothricine, procede pour leur production, compositions pharmaceutiques les contenant et leur utilisation